Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 2,442 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Mr. Andrew Dudum 2016 'den beri şirketle birlikte olan Hims & Hers Health Inc 'in Chairman of the Board 'ıdır.
HIMS hissesinin fiyat performansı nasıl?
HIMS 'in mevcut fiyatı $21.8 'dir, son işlem günde 2.15% arttırılmış etti.
Hims & Hers Health Inc için ana iş temaları veya sektörler nelerdir?
Hims & Hers Health Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Hims & Hers Health Inc 'in piyasa değerlemesi nedir?
Hims & Hers Health Inc 'in mevcut piyasa değerlemesi $4.9B 'dir
Hims & Hers Health Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 16 analist Hims & Hers Health Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 5 al, 9 tut, 1 sat ve 4 güçlü sat içermektedir